Outpatient prescription drug use by children enrolled in five drug benefit plans

被引:21
作者
Hong, SH [1 ]
Shepherd, MD [1 ]
机构
[1] UNIV TEXAS,COLL PHARM,PHARM ADM DIV,AUSTIN,TX 78712
关键词
D O I
10.1016/S0149-2918(96)80035-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study examined prescription drug use among ambulatory children younger than 18 years of age enrolled in five drug benefit plans. Data for this study were obtained from the pharmacy benefit manager who administers the drug benefit plans. During the study period of December 29, 1992, through December 28, 1993, 3144 children younger than 18 years of age (34.0% of the total plan enrollment) were enrolled in the five drug benefit plans. A total of 8547 prescription drugs were dispensed to the study population. The mean prescription price was $16.38, and the mean duration of therapy was 11.7 days. The mean prescription price was $1.56 more for boys than for girls. The most frequently dispensed drugs were antibiotics (42.0%), followed by cold preparations (15.9%). The annual prevalence rate of prescription drug use was 59.1 cases per 100 children. The study population-based annual frequency rate was 3.2 prescriptions per child, and the drug user-based annual frequency rate was 5.5 prescriptions per child. The annual expenditures were $51.85 per child and $90.39 per drug user, with the out-of-pocket expenditures being $19.09 and $33.04, respectively. The prevalence rate varied little by sex. However, both frequency and expenditure rates differed by sex and decreased with age. Higher levels of cost sharing pet prescription were associated with higher prevalence, frequency, and expenditure rates. Larger cost-sharing differentials between generic and brand name drugs were associated with higher rates of generic drug use but were not always associated with lower expenditure rates.
引用
收藏
页码:528 / 545
页数:18
相关论文
共 16 条
[1]  
*AM AC PED, 1994, MED STAT REP TEX FY, P3
[2]  
American Society for Testing and Material ASTM C25, 1993, AHFS DRUG INF 93 AM, P9
[3]   DRUG-USE IN THE UNITED-STATES IN 1981 [J].
BAUM, C ;
KENNEDY, DL ;
FORBES, MB ;
JONES, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (10) :1293-1297
[4]   IMPLEMENTATION OF AN OUTPATIENT PRESCRIPTION DRUG FORMULARY IN A MANAGED-CARE SYSTEM [J].
BLACK, J ;
GRIFFIN, T ;
BEISEL, NW ;
BARTELS, MD .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (03) :561-565
[5]   PHARMACIST-MANAGED MEDICATION REVIEW IN A MANAGED CARE SYSTEM [J].
BORGSDORF, LR ;
MIANO, JS ;
KNAPP, KK .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (06) :772-777
[6]   DRUG PRESCRIPTION IN YOUNG-CHILDREN - RESULTS OF A SURVEY IN FRANCE [J].
COLLET, JP ;
BOSSARD, N ;
FLORET, D ;
GILLET, J ;
HONEGGER, D ;
BOISSEL, JP .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (05) :489-491
[7]  
*FAM US FDN, 1992, PRESCR COSTS AM OTH, P2
[8]   PRESCRIPTION MEDICATIONS IN INFANCY AND EARLY-CHILDHOOD [J].
FOSARELLI, P ;
WILSON, M ;
DEANGELIS, C .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (07) :772-775
[9]   DRUG-RELATED MORBIDITY AND MORTALITY - A COST-OF-ILLNESS MODEL [J].
JOHNSON, JA ;
BOOTMAN, JL .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (18) :1949-1956
[10]  
KASPER JA, 1982, 823320 DHHS PHS